Literature DB >> 22678823

Inflammatory immune responses in tumor microenvironment and metastasis of hepatocellular carcinoma.

Lun-Xiu Qin1.   

Abstract

Metastasis is a multistage process that requires cancer cells to escape from the primary tumor, survive in the circulation, seed at distant sites and grow. Each of these processes involves rate-limiting steps that are influenced by non-malignant cells of the tumor microenvironment. There are growing evidences that tumors are sustained and promoted by inflammatory signals from the surrounding microenvironment. This review describes experimental data demonstrating the role of the inflammatory immune responses of microenvironment in metastases of hepatocellular carcinoma (HCC), points out the prospective areas for future research and possible new therapeutic approaches to control the metastasis of HCC.

Entities:  

Year:  2012        PMID: 22678823      PMCID: PMC3460054          DOI: 10.1007/s12307-012-0111-1

Source DB:  PubMed          Journal:  Cancer Microenviron        ISSN: 1875-2284


  58 in total

Review 1.  Cancer metastasis: building a framework.

Authors:  Gaorav P Gupta; Joan Massagué
Journal:  Cell       Date:  2006-11-17       Impact factor: 41.582

Review 2.  Liver regeneration.

Authors:  Nelson Fausto; Jean S Campbell; Kimberly J Riehle
Journal:  Hepatology       Date:  2006-02       Impact factor: 17.425

3.  Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3.

Authors:  Runqiu Jiang; Zhongming Tan; Lei Deng; Yun Chen; Yongxiang Xia; Yun Gao; Xuehao Wang; Beicheng Sun
Journal:  Hepatology       Date:  2011-08-08       Impact factor: 17.425

4.  Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients.

Authors:  Masahiro Okamoto; Tohru Utsunomiya; Shigeki Wakiyama; Masaji Hashimoto; Kengo Fukuzawa; Takahiro Ezaki; Taizo Hanai; Hiroshi Inoue; Masaki Mori
Journal:  Ann Surg Oncol       Date:  2006-05-23       Impact factor: 5.344

5.  Infiltrating memory/senescent T cell ratio predicts extrahepatic metastasis of hepatocellular carcinoma.

Authors:  Qiang Gao; Jian Zhou; Xiao-Ying Wang; Shuang-Jian Qiu; Kang Song; Xiao-Wu Huang; Jian Sun; Ying-Hong Shi; Bai-Zhou Li; Yong-Sheng Xiao; Jia Fan
Journal:  Ann Surg Oncol       Date:  2011-07-27       Impact factor: 5.344

6.  Human tumor-induced and naturally occurring Treg cells differentially affect NK cells activated by either IL-2 or target cells.

Authors:  Christoph Bergmann; Clarissa A Wild; Mustafa Narwan; Ramin Lotfi; Stephan Lang; Sven Brandau
Journal:  Eur J Immunol       Date:  2011-10-26       Impact factor: 5.532

7.  Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment.

Authors:  Anuradha Budhu; Marshonna Forgues; Qing-Hai Ye; Hu-Liang Jia; Ping He; Krista A Zanetti; Udai S Kammula; Yidong Chen; Lun-Xiu Qin; Zhao-You Tang; Xin Wei Wang
Journal:  Cancer Cell       Date:  2006-08       Impact factor: 31.743

Review 8.  The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression.

Authors:  Francois Ghiringhelli; Cédric Ménard; Francois Martin; Laurence Zitvogel
Journal:  Immunol Rev       Date:  2006-12       Impact factor: 12.988

9.  Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma.

Authors:  Valerie Chew; Jinmiao Chen; Deming Lee; Evelyn Loh; Joyce Lee; Kiat Hon Lim; Achim Weber; Ksenija Slankamenac; Ronnie T P Poon; Henry Yang; London Lucien P J Ooi; Han Chong Toh; Mathias Heikenwalder; Irene O L Ng; Alessandra Nardin; Jean-Pierre Abastado
Journal:  Gut       Date:  2011-09-19       Impact factor: 23.059

10.  Regulatory mechanisms of interleukin-8 production induced by tumour necrosis factor-α in human hepatocellular carcinoma cells.

Authors:  Yaohui Wang; Weimin Wang; Lingyan Wang; Xiangdong Wang; Jinglin Xia
Journal:  J Cell Mol Med       Date:  2012-03       Impact factor: 5.310

View more
  24 in total

Review 1.  Systems Challenges of Hepatic Carcinomas: A Review.

Authors:  Dhatri Madduru; Johny Ijaq; Sujata Dhar; Saumyadip Sarkar; Naresh Poondla; Partha S Das; Silvia Vasquez; Prashanth Suravajhala
Journal:  J Clin Exp Hepatol       Date:  2018-05-17

2.  The hepatitis B virus-associated tumor microenvironment in hepatocellular carcinoma.

Authors:  Pengyuan Yang; Geoffrey J Markowitz; Xiao-Fan Wang
Journal:  Natl Sci Rev       Date:  2014-07-14       Impact factor: 17.275

3.  Inflammation-Dependent IL18 Signaling Restricts Hepatocellular Carcinoma Growth by Enhancing the Accumulation and Activity of Tumor-Infiltrating Lymphocytes.

Authors:  Geoffrey J Markowitz; Pengyuan Yang; Jing Fu; Gregory A Michelotti; Rui Chen; Jianhua Sui; Bin Yang; Wen-Hao Qin; Zheng Zhang; Fu-Sheng Wang; Anna Mae Diehl; Qi-Jing Li; Hongyang Wang; Xiao-Fan Wang
Journal:  Cancer Res       Date:  2016-02-18       Impact factor: 12.701

4.  Imbalance in systemic inflammation and immune response following transarterial chemoembolization potentially increases metastatic risk in huge hepatocellular carcinoma.

Authors:  Tong-Chun Xue; Qing-An Jia; Ning-Ling Ge; Yi Chen; Bo-Heng Zhang; Sheng-Long Ye
Journal:  Tumour Biol       Date:  2015-06-10

Review 5.  Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma.

Authors:  Virginia Hernandez-Gea; Sara Toffanin; Scott L Friedman; Josep M Llovet
Journal:  Gastroenterology       Date:  2013-01-09       Impact factor: 22.682

6.  CD147 promotes Src-dependent activation of Rac1 signaling through STAT3/DOCK8 during the motility of hepatocellular carcinoma cells.

Authors:  Shi-Jie Wang; Hong-Yong Cui; Yan-Mei Liu; Pu Zhao; Yang Zhang; Zhi-Guang Fu; Zhi-Nan Chen; Jian-Li Jiang
Journal:  Oncotarget       Date:  2015-01-01

7.  The impact of inflammatory cells in malignant ascites on small intestinal ICCs' morphology and function.

Authors:  Jing Li; Dan Kong; Yan He; Xiuli Wang; Lei Gao; Jiade Li; Meisi Yan; Duanyang Liu; Yufu Wang; Lei Zhang; Xiaoming Jin
Journal:  J Cell Mol Med       Date:  2015-06-18       Impact factor: 5.310

8.  Loss of PGRMC1 Delays the Progression of Hepatocellular Carcinoma via Suppression of Pro-Inflammatory Immune Responses.

Authors:  Sang R Lee; Jong Geol Lee; Jun H Heo; Seong Lae Jo; Jihoon Ryu; Globinna Kim; Jung-Min Yon; Myeong Sup Lee; Geun-Shik Lee; Beum-Soo An; Hyun-Jin Shin; Dong-Cheol Woo; In-Jeoung Baek; Eui-Ju Hong
Journal:  Cancers (Basel)       Date:  2021-05-18       Impact factor: 6.639

9.  Expression pattern of tumour-associated antigens in hepatocellular carcinoma: association with immune infiltration and disease progression.

Authors:  J Liang; T Ding; Z-W Guo; X-J Yu; Y-Z Hu; L Zheng; J Xu
Journal:  Br J Cancer       Date:  2013-07-18       Impact factor: 7.640

10.  The role of EGF-EGFR signalling pathway in hepatocellular carcinoma inflammatory microenvironment.

Authors:  Peixin Huang; Xiaojing Xu; Lingyan Wang; Bijun Zhu; Xiangdong Wang; Jingling Xia
Journal:  J Cell Mol Med       Date:  2013-11-25       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.